Loading ARQT...
Arcutis Biotherapeutics Inc.ARQTAs of 31 July 2026
−9
PositiveNegative
Equilibrium
Asymmetry
Is Arcutis Biotherapeutics Inc. a good buy right now?
Whether Arcutis Biotherapeutics Inc. (ARQT) looks like a good buy comes down to three things: how it is valued, how the market feels about it, and how strong the underlying business is. Each is measured against Arcutis Biotherapeutics Inc.'s own five-year history, so you see genuine dislocation rather than noise. Information, not advice.
Arcutis Biotherapeutics Inc.ARQTLast 5 years
V—E—F—A—
——
ARQT priceasymmetryquant.com